[Cardiovascular pharmaceuticals: a risk while driving vehicles].
OBJECTIVE
To categorize cardiovascular pharmaceuticals according to their respective effect on one's capacity to drive a vehicle.


METHODS
an analysis of the technical file for 299 pharmaceutical products belonging to 1 lsubgroups inside the main category of therapeutic products related to the cardiovascular apparatus. Information compiled includes: the existence, or lack of, a section which warns of the possible effects of the medication on a person's capacity to drive a vehicle; in those affirmative cases, a statement specifying those effects.


CONCLUSIONS
32.1% of pharmaceutical products do not comply with the existing legislation and approximately half of those pharmaceutical products do not have a section on their effects on a person's capacity to drive a vehicle, or they state these products have an effect but do not bear an influence even though they can provoke important effects.
Alconero Camarero
Ana Rosa
AR
EUE Casade Salud Valdecilla, Universidad de Cantabria. alconear@unican.es
Sangrador Rasero
Ana
A
Casaus Pérez
María
M
Mirones Valdeolivas
Luz Elena
LE
Muñoz Cacho
Pedro
P
D001334:Automobile Driving; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004348:Drug Labeling / Q000706:statistics & numerical data*; D006801:Humans; D012307:Risk Factors